Current knowledge of microRNA-mediated regulation of drug metabolism in humans.

作者: Masataka Nakano , Miki Nakajima

DOI: 10.1080/17425255.2018.1472237

关键词:

摘要: Introduction: Understanding the factors causing inter- and intra-individual differences in drug metabolism potencies is required for practice of personalized or precision medicine, as well f...

参考文章(105)
Scott M. Hammond, An overview of microRNAs Advanced Drug Delivery Reviews. ,vol. 87, pp. 3- 14 ,(2015) , 10.1016/J.ADDR.2015.05.001
Dianke Yu, Bridgett Green, William H. Tolleson, Yaqiong Jin, Nan Mei, Yongli Guo, Helen Deng, Igor Pogribny, Baitang Ning, MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells Biochemical Pharmacology. ,vol. 98, pp. 215- 223 ,(2015) , 10.1016/J.BCP.2015.08.094
S Ding, B G Lake, T Friedberg, C R Wolf, Expression and alternative splicing of the cytochrome P-450 CYP2A7. Biochemical Journal. ,vol. 306, pp. 161- 166 ,(1995) , 10.1042/BJ3060161
Hermann M. Bolt, Peter H. Roos, Ricarda Thier, The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. International Archives of Occupational and Environmental Health. ,vol. 76, pp. 174- 185 ,(2003) , 10.1007/S00420-002-0407-4
Inik Chang, Yozo Mitsui, Shinichiro Fukuhara, Ankurpreet Gill, Darryn K. Wong, Soichiro Yamamura, Varahram Shahryari, Z. Laura Tabatabai, Rajvir Dahiya, Dong Min Shin, Yuichiro Tanaka, Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma. Oncotarget. ,vol. 6, pp. 7774- 7787 ,(2015) , 10.18632/ONCOTARGET.3484
C. Lisa Kurtz, Emily E. Fannin, Cynthia L. Toth, Daniel S. Pearson, Kasey C. Vickers, Praveen Sethupathy, Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver Scientific Reports. ,vol. 5, pp. 12911- 12911 ,(2015) , 10.1038/SREP12911
K.-I. Nunoya, Y. Funae, Y. Kuroiwa, T. Yokoi, K. Nagashima, T. Yamamoto, T. Kamataki, K. Inoue, N. Shimada, M. Nakajima, Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metabolism and Disposition. ,vol. 24, pp. 1212- 1217 ,(1996)
Dhilushi D. Wijayakumara, Dong Gui Hu, Robyn Meech, Ross A. McKinnon, Peter I. Mackenzie, Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. Journal of Pharmacology and Experimental Therapeutics. ,vol. 354, pp. 417- 425 ,(2015) , 10.1124/JPET.115.226118
Joyce A. Goldstein, Clinical relevance of genetic polymorphisms in the human CYP2C subfamily British Journal of Clinical Pharmacology. ,vol. 52, pp. 349- 355 ,(2001) , 10.1046/J.0306-5251.2001.01499.X